BioWorld12d
Epigenetic editing demonstrates long-lasting control of LDL-C levels in vivo by targeting PCSK9
Epigenetic editing is a promising method for gene regulation in vitro and in vivo, allowing precise control of gene ...
Business Wire7d
Scribe Therapeutics Presents Data on its Epigenetic Long-Term X-Repressor Technology at the 2025 Keystone Symposia on Precision Genome Engineering Conference
ELXR offers a promising epigenetic editing approach to treat ... world-leading pharmaceutical companies including Sanofi and Eli Lilly. Co-founded by Nobel Prize winner Jennifer Doudna and backed ...
Eli Lilly posts long-term data for eczema therapy Ebglyss
Eli Lilly (NYSE:LLY) on Friday said that its recently approved eczema therapy Ebglyss led to complete skin clearance in 50% ...